Dietary intervention in infancy and later signs of beta-cell autoimmunity

New England Journal of Medicine

Volumn 363, Issue 20, 2010, Pages 1900-1908

  Knip, Mikael ^a,d   Virtanen, Suvi M ^b,d,e   Seppä, Karri ^c   Ilonen, Jorma ^f,g   Savilahti, Erkki ^a   Vaarala, Outi ^b   Reunanen, Antti ^b   Teramo, Kari ^a   Hämäläinen, Anu Maaria ^h,i   Paronen, Johanna ^a   Dosch, Hans Michael ^j   Hakulinen, Timo ^c   Åkerblom, Hans K ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c FINNISH CANCER REGISTRY   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF TAMPERE   (Finland)

^f UNIVERSITY OF TURKU   (Finland)

^g UNIVERSITY OF EASTERN FINLAND   (Finland)

^h JORVI HOSPITAL   (Finland)

ⁱ UNIVERSITY OF OULU   (Finland)

^j UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CASEIN HYDROLYSATE; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN ANTIBODY; INSULINOMA ASSOCIATED 2 MOLECULE ANTIBODY; PANCREAS ISLET CELL ANTIBODY; UNCLASSIFIED DRUG; ZINC TRANSPORTER 8 ANTIBODY;

ANTIBODY BLOOD LEVEL; ARTICLE; ARTIFICIAL MILK; BREAST MILK; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DOUBLE BLIND PROCEDURE; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HLA TYPING; HUMAN; IMMUNOFLUORESCENCE; INFANCY; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RADIOASSAY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEROCONVERSION; TREATMENT DURATION;

EID: 78149475225     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1004809     Document Type: Article

References (31)

1. Knip M. Natural course of preclinical type 1 diabetes. Horm Res 2002;57:Suppl 1: 6-11.
2. Idem. Can we predict type 1 diabetes in the general population? Diabetes Care 2002;25:623-5.
3. Wenzlau JM, Juhl K, Yu L, et al. The cation transporter ZnT8 (Slc30A8) is a major antigen in human type 1 diabetes. Proc Natl Acad Sci U S A 2007;104:17040-5.
4. Knip M. Should we screen for risk of type 1 diabetes? Diabetes Care 2008;31: 622-3.
5. Ziegler A-G, Hummel M, Schenker M, Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 1999;48: 460-8.
6. Kimpimäki T, Kupila A, Hämäläinen A-M, et al. The first signs of β-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study. J Clin Endocrinol Metab 2001;86:4782-8.
7. Harjutsalo V, Sjöberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 2008;371:1777-82.
8. Patterson CC, Dahlquist CG, Gyürüs E, Green A, Soltész G. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009;373:2027-33.
9. Virtanen SM, Knip M. Nutritional risk predictors of β cell autoimmunity and type 1 diabetes at a young age. Am J Clin Nutr 2003;78:1053-67.
10. Knip M, Virtanen SM, Åkerblom HK. Infant feeding and risk of type 1 diabetes. Am J Clin Nutr 2010;91:Suppl:1506S-1513S.
11. Karges W, Hammond-McKibben D, Cheung RK, et al. Immunological aspects of nutritional diabetes prevention in NOD mice: a pilot study for the cow's milk-based IDDM prevention trial. Diabetes 1997;46:557-64.
12. Malkani S, Nompleggi D, Hansen JW, Greiner DL, Mordes JP, Rossini AA. Dietary cow's milk protein does not alter the frequency of diabetes in the BB rat. Diabetes 1997;46:1133-40.
13. Paxson JA, Weber JG, Kulzycki A Jr. Cow's milk-free diet does not prevent diabetes in NOD mice. Diabetes 1997;46:1711-7. [Erratum, Diabetes 1998;47:144.]
14. Simonson W, Ramanathan S, Bieg S, Poussier P, Lernmark A. Protein-free diets do not protect high-incidence diabetesprone BioBreeding rats from diabetes. Metabolism 2002;51:569-74.
15. Åkerblom HK, Virtanen SM, Ilonen J, et al. Dietary manipulation of beta-cell autoimmunity in infants at increased risk for type 1 diabetes. Diabetologia 2005;48: 829-37.
16. Ilonen J, Reijonen H, Herva E, et al. Rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. Diabetes Care 1996;19:795-800. (Pubitemid 26286981)
17. Sjöroos M, Iitiä A, Ilonen J, Reijonen H, Lövgren T. Triple-label hybridization assay for type-1 diabetes-related HLA alleles. Biotechniques 1995;18:870-7.
18. Kukko M, Kimpimäki T, Korhonen S, et al. Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 2005;90:2712-7.
19. Reunanen A, Kangas T, Martikainen J, Klaukka T. Nationwide survey of comorbidity, use, and costs of all medications in Finnish diabetic individuals. Diabetes Care 2000;23:1265-71.
20. Turnbull BW. The empirical distribution function with arbitrarily grouped, censored and truncated data. J R Stat Soc B 1976;38:290-5.
21. Royston P, Parmar MKB. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med 2002;21:2175-97.
22. R Development Core Team. R: a language and environment for statistical computing. 2009. (www.R-project.org.)
23. The TRIGR Study Group. Study design of the Trial to Reduce IDDM in the Genetically at Risk (TRIGR). Pediatr Diabetes 2007;8:117-37.
24. Virtanen SM, Räsänen L, Aro A, et al. Infant feeding in Finnish children <7 yr of age with newly diagnosed IDDM. Diabetes Care 1991;14:415-7.
25. Siljander HT, Simell S, Hekkala A, et al. Predictive value of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility recruited from the general population. Diabetes 2009;58:2835-42.
26. Visser JT, Bos NA, van Tool EA, Harthoorn LC, Rozing J. Differential preventive effect of casein hydrolysates in autoimmune diabetes development involves intestinal barrier integrity and gut flora composition. Eur J Immunol 2009;39: Suppl 1:S674.
27. Norris JM, Barriga K, Klingensmith G, et al. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 2003;290:1713-20.
28. Ziegler A-G, Schmid S, Huber D, Hummel M, Bonifacio E. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 2003; 290:1721-8.
29. Virtanen SM, Kenward MG, Erkkola M, et al. Age at introduction of new foods and advanced beta-cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes. Diabetologia 2006;49:1512-21.
30. Holmberg H, Wahlberg J, Vaarala O, Ludvigsson J. Short duration of breast-feeding as a risk-factor for beta-cell autoantibodies in 5-year-old children from the general population. Br J Nutr 2007;97: 111-6.
31. EURODIAB ACE Study Group, EURODIAB ACE Substudy 2 Study Group. Familial risk of type I diabetes in European children. Diabetologia 1998;41:1151-6.